Skip to main content
GutCited
Figure 2. The effect of probiotic intervention on clinical improvement assessed by IBS-SSS scores (a–f). * indicates a statistically significant improvement (p < 0.05) between both the groups given probiotic intervention and the placebo group in the tot
Figure 7. Figure 2. The effect of probiotic intervention on clinical improvement assessed by IBS-SSS scores (a–f). * indicates a statistically significant improvement (p < 0.05) between both the groups given probiotic intervention and the placebo group in the total IBS-SSS score (a), and between the Bifidobacterium lactis BI040 group and the placebo group in the IBS-SSS2 score assessing the frequency of pain (c); # p-value = 0.054 between the Bacillus coagulans BC300 group and the placebo group (c).

Deskripsi

Probiotic intervention outcomes assessed by IBS Severity Scoring System (IBS-SSS) in a three-arm clinical trial. Both Bifidobacterium lactis BI040 and Bacillus coagulans BC300 groups showed statistically significant improvement in total IBS-SSS scores compared to placebo.

More Figures from This Paper

Supplementary outcome data from the randomized trial evaluating single-strain probiotics for irritable bowel syndrome, comparing gastrointestinal symptom improvements across treatment arms.

Figure 6

Supplementary outcome data from the randomized trial evaluating single-strain probiotics for irritable bowel syndrome, comparing gastrointestinal symptom improvements across treatment arms.

chart
Supplementary outcome data from the randomized trial evaluating single-strain probiotics for irritable bowel syndrome, comparing gastrointestinal symptom improvements across treatment arms.

Figure 8

Supplementary outcome data from the randomized trial evaluating single-strain probiotics for irritable bowel syndrome, comparing gastrointestinal symptom improvements across treatment arms.

chart
Supplementary outcome data from the randomized trial evaluating single-strain probiotics for irritable bowel syndrome, comparing gastrointestinal symptom improvements across treatment arms.

Figure 9

Supplementary outcome data from the randomized trial evaluating single-strain probiotics for irritable bowel syndrome, comparing gastrointestinal symptom improvements across treatment arms.

chart

Figure 7

Chart
685 × 648px · 174,2 KB

Source Paper

The Efficacy and Safety of Single-Strain Probiotic Formulations Containing Bifidobacterium lactis or Bacillus coagulans in Adult Patients with Irritable Bowel …

Journal of clinical medicine (2023)

PMID: 37510953

DOI: 10.3390/jcm12144838

Cite This Figure

![Figure 7: Probiotic intervention outcomes assessed by IBS Severity Scoring System (IBS-SSS) in a three-arm clinical trial. Both Bifidobacterium lactis BI040 and Bacillus coagulans BC300 groups showed statistically significant improvement in total IBS-SSS scores compared to placebo.](https://pdfs.citedhealth.com/figures/37510953/222.png)

> Source: Barbara Skrzydło-Radomańska et al. "The Efficacy and Safety of Single-Strain Probiotic Formulations Containing Bifid." *Journal of clinical medicine*, 2023. PMID: [37510953](https://pubmed.ncbi.nlm.nih.gov/37510953/)
<figure>
  <img src="https://pdfs.citedhealth.com/figures/37510953/222.png" alt="Probiotic intervention outcomes assessed by IBS Severity Scoring System (IBS-SSS) in a three-arm clinical trial. Both Bifidobacterium lactis BI040 and Bacillus coagulans BC300 groups showed statistically significant improvement in total IBS-SSS scores compared to placebo." />
  <figcaption>Figure 7. Probiotic intervention outcomes assessed by IBS Severity Scoring System (IBS-SSS) in a three-arm clinical trial. Both Bifidobacterium lactis BI040 and Bacillus coagulans BC300 groups showed statistically significant improvement in total IBS-SSS scores compared to placebo.<br>  Source: Barbara Skrzydło-Radomańska et al. "The Efficacy and Safety of Single-Strain Probiotic Formulations Containing Bifid." <em>Journal of clinical medicine</em>, 2023. PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/37510953/">37510953</a></figcaption>
</figure>

Bukti Terkait

B
Bacillus coagulans untuk Irritable Bowel Syndrome (IBS)

Peringkat B · 3 studi

 B
Bifidobacterium lactis untuk Chronic Constipation

Peringkat B · 4 studi